Latest Investor Relations News

Shaver Shop Group Limited reported a record gross margin of 45.5% and EBIT growth of 2.4% in FY25, alongside a strong fully franked dividend. The 2025 AGM saw shareholder approval of key governance items including executive incentives.

ECS Botanics has successfully raised nearly A$2 million through a placement aimed at accelerating its international expansion and product development. The move underscores growing investor confidence in the medicinal cannabis company’s strategic growth plans.

Unith Ltd has secured new contracts and expanded its strategic partnerships while advancing its ISO 27001 certification, signaling strong momentum in its AI digital human technology business.

Sagalio Energy Limited’s shares have been suspended from ASX trading due to compliance concerns, leaving investors in the dark about the company’s next steps.

CVC Limited has announced a $50 million offer of unsecured, redeemable notes, combining a reinvestment option for existing holders with a new money offer for fresh investors. The notes will pay a floating quarterly interest and are expected to trade on the ASX under code CVCHB.

Megaport Limited has successfully completed a A$200 million institutional placement to fund its acquisition of Latitude.sh and accelerate network growth in India, signaling a strategic push into hybrid cloud and AI-driven infrastructure.

Aristocrat Leisure reported robust FY25 results with 11% revenue growth to A$6.3 billion and a 12% rise in NPATA, fueled by strong performances across its gaming segments and strategic acquisitions. The company signals continued profit growth in FY26, underpinned by organic expansion and market share gains.

Vectus Biosystems has responded to an ASX price query following a dramatic spike in its share price and trading volume, denying any undisclosed information and confirming compliance with ASX rules.

American West Metals has begun trading on the OTCQB Venture Exchange, boosting its visibility among US investors and signaling potential future listings on major US exchanges amid rising demand for domestic critical minerals.

Mayfield Group Holdings has completed a $30.5 million private placement and launched a $3 million share purchase plan to fund growth initiatives, including acquisitions and capacity expansion.

Invex Therapeutics Ltd has had its trading suspension lifted following an announcement of new board and officer appointments, signaling a fresh chapter for the biotech company.

Memphasys Limited has successfully raised over $1.1 million through a pro-rata entitlement offer to accelerate the commercialisation of its innovative Felix™ sperm selection system, targeting key regulatory approvals and market expansion.